BGM (BGM Group) Debt-to-Revenue : 0.00 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BGM Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BGM Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. BGM Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. BGM Group's annualized Revenue for the quarter that ended in Sep. 2024 was $25.07 Mil. BGM Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.00.

BGM Group Debt-to-Revenue Historical Data

The historical data trend for BGM Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group Debt-to-Revenue Chart

BGM Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Debt-to-Revenue

Get a 7-Day Free Trial

0.15

0.14

0.03

0.01

BGM Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Debt-to-Revenue	Get a 7-Day Free Trial										0.03	0.01	0.02	-	-

Competitive Comparison of BGM Group's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BGM Group's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BGM Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BGM Group's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

BGM Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BGM Group's Debt-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	25.098
	=	0.00

BGM Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	25.07
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2024) Revenue data.

BGM Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BGM Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BGM Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200

Website

https://www.bgmgroupltd.com

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.